Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06336967 · ClinicalTrials.gov registry record · NA
Testing a Wellness App for First Responders, Military Personnel and Veterans
A NA study of Mental Health Wellness, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
- 1
- Study location
NCT06336967: Completed NA study of Mental Health Wellness, sponsored by University of Pennsylvania.
NCT06336967 is a NA study of Mental Health Wellness that has completed, run by University of Pennsylvania. The registered enrollment target is 115 participants, below the 387-participant average among 8 other Mental Health Wellness trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06336967, a NA study of Mental Health Wellness, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research study is to trial a smart phone application, the GUIDE App, to better understand its impact on social connectedness, personal growth and mental health/wellness among first responders, soldiers, and veterans. The research team will also investigate workplace metrics (e.g., engagement and burnout), implementation outcomes and technical merit. The investigators plan to run a three-armed randomized waitlist pilot feasibility trial with up to 150 participants.
Primary Outcome
The PERMA-Profiler is designed to measure the general wellbeing of adults; specifically this questionnaire measures positive and negative emotions, engagement, relationships, meaning, accomplishment, and health. Participants respond to 23 items on an 11-point Likert scale, from 0 to 10. Scores are calculated as the average of the items comprising each factor. Lower scores indicate lower flourishing, and higher scores indicate higher flourishing.
Conditions Studied
Interventions
- BEHAVIORAL GUIDE
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2024-04-22 |
| Est. Completion | 2024-10-01 |
| Phase | NA |
What the finished NCT06336967 record still lists
NCT06336967 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 387-participant average among 8 other Mental Health Wellness trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Mental Health Wellness appearing as the primary indexed condition, and to 1 intervention - of which GUIDE is the first listed.
NCT06336967 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06336967 about?
NCT06336967 is a clinical study titled "Testing a Wellness App for First Responders, Military Personnel and Veterans". The purpose of the research study is to trial a smart phone application, the GUIDE App, to better understand its impact on social connectedness, personal growth and mental health/wellness among first responders, soldiers, and veterans. The research team will also investigate workplace metrics (e.g.,...
What is the current status of trial NCT06336967?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2024-04-22. Estimated completion is 2024-10-01.
What conditions does trial NCT06336967 study?
This clinical trial studies the following conditions: Mental Health Wellness.
What interventions are being tested in trial NCT06336967?
The interventions under investigation include: GUIDE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06336967?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06336967 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Health Wellness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06336967's enrollment target sits among peer trials
115 7th of 8 higher than 2 of 8 other Mental Health Wellness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mental Health Wellness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Pilot Testing of a Structural Racism Intervention for Immigrant Latinx Families
RECRUITING · NA
-
Harlem Strong Mental Health Coalition
RECRUITING · NA
-
Health Without Barriers/Salud Sin Barreras
RECRUITING · NA
-
Wellbeing of the ECE Workforce in Low-resourced Locations
ACTIVE NOT RECRUITING · NA
-
The IGNITE for Kids Study on Concentrated Investment in Black Neighborhoods and Child Health and Well-Being
ACTIVE NOT RECRUITING · NA
-
Brief Online Intervention for Veterans
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI